HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients

Journal of Virology

Volumn 84, Issue 14, 2010, Pages 7412-7415

  Skar, Helena ^a,b,c   Borrego, Pedro ^d   Wallstrom, Timothy C ^e   Mild, Mattias ^a,b   Marcelino, José Maria ^f   Barroso, Helena ^d,g   Taveira, Nuno ^d,g   Leitner, Thomas ^c   Albert, Jan ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^e LOS ALAMOS NATIONAL LABORATORY   (United States)

^f INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^g INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN 125; UNCLASSIFIED DRUG;

ARTICLE; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRULENCE;

DNA, VIRAL; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; SELECTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 77953755556     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02548-09     Document Type: Article

References (36)

1. Alatrakchi, N., F. Damond, S. Matheron, S. Beretta-Tempelhoff, P. Campa, G. Carcelain, F. Brun-Vezinet, and B. Autran. 2006. Proliferative, IFN-gamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection. AIDS 20:29-34.
2. Andersson, S., H. Norrgren, Z. da Silva, A. Biague, S. Bamba, S. Kwok, C. Christopherson, G. Biberfeld, and J. Albert. 2000. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch. Intern. Med. 160:3286-3293.
3. Barroso, H., and N. Taveira. 2005. Evidence for negative selective pressure in HIV-2 evolution in vivo. Infect. Genet. Evol. 5:239-346.
4. Bjorling, E., G. Scarlatti, A. von Gegerfelt, J. Albert, G. Biberfeld, F. Chiodi, E. Norrby, and E. M. Fenyo. 1993. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 193:528-530. (Pubitemid 23192835)
5. Borrego, P., J. M. Marcelino, C. Rocha, M. Doroana, F. Antunes, F. Maltez, P. Gomes, C. Novo, H. Barroso, and N. Taveira. 2008. The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients. Retrovirology 5:78.
6. Bour, S., and K. Strebel. 1996. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70:8285-8300.
7. Cavaleiro, R., G. J. Brunn, A. S. Albuquerque, R. M. Victorino, J. L. Platt, and A. E. Sousa. 2007. Monocyte-mediated T cell suppression by HIV-2 envelope proteins. Eur. J. Immunol. 37:3435-3444.
8. Cavaleiro, R., A. E. Sousa, A. Loureiro, and R. M. Victorino. 2000. Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS 14:2679-2686.
9. Choisy, M., C. H. Woelk, J. F. Guegan, and D. L. Robertson. 2004. Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J. Virol. 78:1962-1970.
10. Delwart, E. L., H. Pan, H. W. Sheppard, D. Wolpert, A. U. Neumann, B. Korber, and J. I. Mullins. 1997. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J. Virol. 71:7498-7508.
11. de Silva, T. I., M. Cotten, and S. L. Rowland-Jones. 2008. HIV-2: the forgotten AIDS virus. Trends Microbiol. 16:588-595.
12. Drummond, A. J., and A. Rambaut. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7:214.
13. Duvall, M. G., A. Jaye, T. Dong, J. M. Brenchley, A. S. Alabi, D. J. Jeffries, M. van der Sande, T. O. Togun, S. J. McConkey, D. C. Douek, A. J. McMichael, H. C. Whittle, R. A. Koup, and S. L. Rowland-Jones. 2006. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176:6973-6981.
14. Duvall, M. G., M. L. Precopio, D. A. Ambrozak, A. Jaye, A. J. McMichael, H. C. Whittle, M. Roederer, S. L. Rowland-Jones, and R. A. Koup. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 38:350-363.
15. Edwards, C. T., E. C. Holmes, O. G. Pybus, D. J. Wilson, R. P. Viscidi, E. J. Abrams, R. E. Phillips, and A. J. Drummond. 2006. Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics 174:1441-1453.
16. Elena, S. F., C. O. Wilke, C. Ofria, and R. E. Lenski. 2007. Effects of population size and mutation rate on the evolution of mutational robustness. Evolution 61:666-674.
17. -/- humanized mouse model. J. Virol. 84:2740-2752.
18. Koblavi-Deme, S., L. Kestens, D. Hanson, R. A. Otten, M. Y. Borget, C. Bile, S. Z. Wiktor, T. H. Roels, T. Chorba, and J. N. Nkengasong. 2004. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Cote D'Ivoire. AIDS 18:413-419.
19. Lee, H. Y., A. S. Perelson, S. C. Park, and T. Leitner. 2008. Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression. PLoS Comput. Biol. 4:e1000240.
20. Lemey, P., S. L. Kosakovsky Pond, A. J. Drummond, O. G. Pybus, B. Shapiro, H. Barroso, N. Taveira, and A. Rambaut. 2007. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput. Biol. 3:e29.
21. Le Tortorec, A., and S. J. Neil. 2009. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83:11966-11978.
22. MacNeil, A., J. L. Sankale, S. T. Meloni, A. D. Sarr, S. Mboup, and P. Kanki. 2007. Long-term intrapatient viral evolution during HIV-2 infection. J. Infect. Dis. 195:726-733.
23. Maydt, J., and T. Lengauer. 2006. Recco: recombination analysis using cost optimization. Bioinformatics 22:1064-1071.
24. Michel, P., A. T. Balde, C. Roussilhon, G. Aribot, J. L. Sarthou, and M. L. Gougeon. 2000. Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution. J. Infect. Dis. 181:64-75.
25. Mikhail, M., B. Wang, P. Lemey, B. Beckthold, A. M. Vandamme, M. J. Gill, and N. K. Saksena. 2005. Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort. Retrovirology 2:41.
26. Poon, A. F., F. I. Lewis, S. D. Frost, and S. L. Kosakovsky Pond. 2008. Spidermonkey: rapid detection of co-evolving sites using Bayesian graphical models. Bioinformatics 24:1949-1950.
27. Popper, S. J., A. D. Sarr, K. U. Travers, A. Gueye-Ndiaye, S. Mboup, M. E. Essex, and P. J. Kanki. 1999. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J. Infect. Dis. 180:1116-1121.
28. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
29. Salazar-Gonzalez, J. F., E. Bailes, K. T. Pham, M. G. Salazar, M. B. Guffey, B. F. Keele, C. A. Derdeyn, P. Farmer, E. Hunter, S. Allen, O. Manigart, J. Mulenga, J. A. Anderson, R. Swanstrom, B. F. Haynes, G. S. Athreya, B. T. Korber, P. M. Sharp, G. M. Shaw, and B. H. Hahn. 2008. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82:3952-3970.
30. Schindler, M., J. Munch, O. Kutsch, H. Li, M. L. Santiago, F. Bibollet- Ruche, M. C. Muller-Trutwin, F. J. Novembre, M. Peeters, V. Courgnaud, E. Bailes, P. Roques, D. L. Sodora, G. Silvestri, P. M. Sharp, B. H. Hahn, and F. Kirchhoff. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055-1067.
31. Schulz, T. F., D. Whitby, J. G. Hoad, T. Corrah, H. Whittle, and R. A. Weiss. 1990. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J. Virol. 64:5177-5182.
32. Shankarappa, R., J. B. Margolick, S. J. Gange, A. G. Rodrigo, D. Upchurch, H. Farzadegan, P. Gupta, C. R. Rinaldo, G. H. Learn, X. He, X. L. Huang, and J. I. Mullins. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
33. Shi, Y., J. Albert, G. Francis, H. Holmes, and E. M. Fenyo. 2002. A new cell line-based neutralization assay for primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses 18:957-967.
34. Shi, Y., E. Brandin, E. Vincic, M. Jansson, A. Blaxhult, K. Gyllensten, L. Moberg, C. Brostrom, E. M. Fenyo, and J. Albert. 2005. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation. J. Gen. Virol. 86:3385-3396.
35. Shioda, T., S. Oka, X. Xin, H. Liu, R. Harukuni, A. Kurotani, M. Fukushima, M. K. Hasan, T. Shiino, Y. Takebe, A. Iwamoto, and Y. Nagai. 1997. In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression. J. Virol. 71:4871-4881.
36. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169:3400-3406.